Clinical Research Directory
Browse clinical research sites, groups, and studies.
Platelet-Rich Plasma for Peyronie's Disease
Sponsor: Herlev Hospital
Summary
The purpose of this clinical trial is to evaluate the effects of Platelet-Rich Plasma (PRP) intralesional injections in men affected by Peyronie's disease (PD) in the fibrotic phase.
Official title: Treatment of Peyronie's Disease With Platelet-Rich Plasma: A Randomized, Double-blind, Placebo-controlled Clinical Trial
Key Details
Gender
MALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
84
Start Date
2025-09-20
Completion Date
2028-09-01
Last Updated
2025-08-14
Healthy Volunteers
No
Conditions
Interventions
Autologous Platelet Rich Plasma
6 mL PRP intralesional injections will be administered. After the injections, participants will be instructed to perform penile stretching exercises daily until the next injection and to continue these exercises after the final injection until the 3-month follow-up.
Saline solution
6 mL saline solution intralesional injections will be administered. After the injections, participants will be instructed to perform penile stretching exercises daily until the next injection and to continue these exercises after the final injection until the 3-month follow-up.
Locations (1)
Herlev and Gentofte University Hospital
Herlev, Denmark